Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.09, Zacks reports. Coloplast A/S had a net margin of 9.68% and a return on equity of 39.27%.
Coloplast A/S Price Performance
Shares of Coloplast A/S stock opened at $6.75 on Tuesday. The firm has a market cap of $15.21 billion, a price-to-earnings ratio of 35.53, a PEG ratio of 2.56 and a beta of 0.21. Coloplast A/S has a one year low of $5.64 and a one year high of $9.70. The stock’s 50-day moving average is $6.82 and its 200 day moving average is $6.81. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94.
Coloplast A/S Company Profile
Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.
Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.
Featured Stories
- Five stocks we like better than Coloplast A/S
- Check Point’s Turnaround Could Be Closer Than Investors Think
- SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
